
Something big is happening in healthcare, as pharma stocks have recently rallied on breakthrough AI developments that could reshape the entire industry.
The Healthcare Select Sector SPDR Fund (NYSE:XLV) is having its third-best month against the S&P 500 since 1999, and a big part of that momentum has to do with one company: Eli Lilly & Co. (NYSE:LLY).